Recent studies led by Sanford Research scientist Kamesh Surendran, Ph.D., reveal how cell to cell communication between cell types in the developing and adult kidney collecting ducts ensures the water reabsorption capacity.
A critical function of the kidney is water reabsorption, which is carried out in a highly regulated manner. In rare instances children are born with kidneys that do not reabsorb water adequately and may suffer from repeated episodes of dehydration resulting in stunted growth. Additionally, medications such as lithium, prescribed as a therapy for bipolar disorders, as a side-effect disable the kidneys water reabsorption capacity even in adults.
The Surendran Lab is focused on understanding the underlying mechanisms that determine the different cells that make up kidney collecting ducts. They recently published an article describing their work in the research journal Developmental Biology.
The different cell types of the kidney collecting ducts perform unique functions of the kidneys like regulation of water, electrolytes and pH homeostasis. When the kidney collecting ducts malfunction, it can lead to renal disease.
Findings from this study on mice, according to Dr. Surendran, could provide more information on genetic mutations that alter collecting duct cell functions and subsequently identify new human therapy options for diseases in these cells. Additionally, a better understanding of how these cells are made and maintained is essential for generating kidneys from patient-derived adult stem cells.
About 10 percent of U.S. adults, or more than 20 million people, have some degree of chronic kidney disease, the Centers for Disease Control and Prevention reports. According to Johns Hopkins University, around 1 in 500 children are born with abnormally developed kidneys due to genetic defects, which can lead to end-stage kidney disease.
Dr. Surendran sat down to talk with Sanford Health News about his history with Sanford Research and his latest work.
When it was time for me to move on from my post-doctoral training in Dr. Raphael Kopans lab at Washington University in St. Louis, Sanford Research was recruiting faculty to set up independent research programs with a focus on rare diseases. During my post-doctoral training I had stumbled on to a mouse model of the kidney disease that occurs in Alagille syndrome, a rare disease.
Professionally, I wished to set up a research program focused on how the kidney develops in order to understand and prevent what goes wrong in children born with kidney defects. Sanford Research appeared to be a great fit.
Personally, it was time for my family to move to a neighborhood with better schools as my daughter was almost ready to start kindergarten. The public school system in Sioux Falls is a blessing.
My graduate studies looking at kidney repair and regeneration made me realize that we dont really understand how the different cell types of the kidney develop. This led me to focus on understanding the genes and signals critical for normal kidney development during my post-doctoral training.
This paper on Foxi1 is the third one from my lab in a series on the topic of kidney collecting duct cell type differentiation and maintenance which we study using mouse models. The kidney collecting ducts form a branched tree-like tubular network that connects all the nephrons to the ureter and is made of two categories of cell types. Whereas we know quite a bit about the genes that regulate growth and branching of the collecting duct, we know far less about how the cells of the collecting ducts diversify and remain different to perform different specialized functions.
We previously used a novel tool which we refer to as principal cell lineage tracing mice, to prove that mature principal cells directly convert to intercalated cells, following inhibition of Notch signaling that are normally activated in principal cells by ligands expressed on neighboring intercalated cells. Interestingly, lithium treatment which is used to treat bipolar disorders also triggers principal-to-intercalated cell conversion. Patients treated with lithium tend to produce more dilute urine and develop a condition referred to as acquired nephrogenic diabetes insipidus. Since principal cells are important for water absorption to ensure sufficient hydration, this principal-to-intercalated-cell-type conversion may be part of the underlying cause of lithiums side-effect on the kidney.
In this recent paper we have identified how Notch signaling promotes principal cell fate selection during kidney development and in the process identified one way to rescue the principal cell deficiency and the urine concentrating deficiency in mice with reduced Notch signaling in the kidney collecting ducts. It remains to be determined if the kidney side-effects of lithium can be rescued by a similar mechanism.
The principal-to-intercalated-cell-type conversion in adult kidneys is a novel, unexpected finding from our previous study. We are looking into whether this cell type conversion is part of the mechanisms by which the kidney remodels its cell types in order to adapt to dietary changes such as excessive salt intake or an extremely low potassium diet. We are also examining whether certain medications prescribed to counter hypertension involve activation of Notch pathway and cell type conversion. Hence, understanding the mechanism by which Notch signal maintains the principal cells could open new ways to regulate and maintain kidney functions.
Many of the figures in this paper include confocal images which were made possible by the histology and imaging cores. Additionally, we made use of the mouse facility and metabolic cages to study the urine concentrating capacity of the mice. The ongoing work on this project is making use of the functional genomics and bioinformatics core to identify the direct targets of Hes1, and the biochemistry core to identify hes1 interacting proteins. The multitude of core facilities at Sanford Research strengthen our studies.
Malini Mukherjee, who was a post-doc in my lab and is now part of the Functional Genomics and Bioinformatics core, got to present these findings at the annual, internationally attended American Society of Nephrology (ASN) conference. It was exciting to have her abstract on this paper selected for an oral presentation at the end of 2018, which is an accomplishment in itself. Subsequently, I got invited to present a seminar on kidney collecting duct cell type differentiation and maintenance at the 2019 ASN conference. The quality and novelty of our published work has certainly been recognized within the kidney development field. What was pleasing for me is that a prominent kidney physiology researcher attended the talk and appreciated our work. This is important as our research is moving from development to maintenance which is the realm of renal physiologists.
Personally, it is fascinating to see that nature works in ways that is only limited by our imagination. Although Ive understood that mature cell types are actively maintained in a mature state, and had proposed to test if Notch signaling is required for principal cell maintenance, I had not anticipated that mature kidney epithelial cell types can switch directly from one fate to another. To top that, it may turn out that this cell type conversion is part of the way in which the kidney adapts to certain diets to perform its normal functions.
Posted In Health Care Heroes, Research
More here:
Cellular miscommunication may be root of kidney disease - Sanford Health News
- Different Types Of Stem Cells: Embryonic Vs. Adult ... - January 17th, 2025
- Rejuvenation of Aging Adult Stem Cells to Improve their Regenerative Potential - Frontiers - January 13th, 2025
- Hope Biosciences Research Foundation Authorized to Begin Phase II Clinical Trial in Stem Cell Therapy for Juvenile Idiopathic Arthritis - Business... - December 22nd, 2024
- What Are Stem Cells? Biomedical Beat Blog National Institute of ... - November 29th, 2024
- TVHS opens stem cell processing lab to expand biotherapies | VA Tennessee Valley health care | Veterans Affairs - Veterans Affairs - November 8th, 2024
- Understanding Mature Tissue or Organ Stem Cells and Their Clinical ... - November 8th, 2024
- Biology of stem cells: an overview - PMC - PubMed Central (PMC) - October 30th, 2024
- New government tech deals boost the business of cancer detection - GOV.UK - October 11th, 2024
- Stem cell therapy reverses type 1 diabetes in world first - Yahoo News UK - October 11th, 2024
- Advances in different adult stem cell-derived exosomal non-coding RNAs for the treatment of neurological disorders: a narrative review - Frontiers - September 26th, 2024
- Breakthrough technique may help speed understanding, treatment of MD, ALS - Harvard Gazette - September 14th, 2024
- Rostock University Explores Use of Stem Cells for Meat Cultivation with Help from Innocent Meat - vegconomist - the vegan business magazine - August 12th, 2024
- Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program - July 31st, 2024
- Atea Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call on August 7, 2024 - July 31st, 2024
- Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update - July 31st, 2024
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2024 - July 31st, 2024
- Ocular Therapeutix™ to Report Second Quarter 2024 Financial Results on August 7, 2024 - July 31st, 2024
- Kymera Therapeutics to Report Second Quarter 2024 Financial Results on August 7 - July 31st, 2024
- Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline) Demonstrating No Change in In Vitro Potency... - July 31st, 2024
- Targeting the stem cell niche micro-environment as therapeutic strategies in aging - Frontiers - June 28th, 2024
- International trial introduces another curative option for sickle cell disease - EurekAlert - June 28th, 2024
- HOX genes in stem cells: Maintaining cellular identity and regulation of differentiation - Frontiers - June 28th, 2024
- Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - June 21st, 2024
- Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and... - June 21st, 2024
- Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management - June 21st, 2024
- Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC. - June 21st, 2024
- Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Samer Kaba, MD as Chief Medical Officer - June 21st, 2024
- API and the University of Alberta Break Ground in Edmonton on Canada’s Largest Manufacturing Facility for Critical Medicines - June 21st, 2024
- Syntekabio Signs Memorandum of Understanding with bioSeedin/ACROBiosystems - June 21st, 2024
- Rapafusyn Pharmaceuticals Secures $28 Million Series A to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform - June 21st, 2024
- Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog... - June 21st, 2024
- Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual General Meeting - June 21st, 2024
- Cellectis Publishes a Scientific Article Unveiling Three Key Factors for Efficient TALE Base Editing - June 21st, 2024
- NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - June 21st, 2024
- Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran - June 21st, 2024
- Idorsia’s novel treatment for chronic insomnia wins the prestigious Prix Galien Suisse 2024 innovation award in the ‘Primary & Speciality’... - June 21st, 2024
- Radiopharm Receives Strategic Investment for up to A$18 million - June 21st, 2024
- Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee - June 21st, 2024
- Trading by management and close relations of management - June 21st, 2024
- Major shareholder announcement - June 21st, 2024
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - June 21st, 2024
- Nature retracts highly cited 2002 paper that claimed adult stem cells could become any type of cell - Retraction Watch - June 19th, 2024
- Shares of Biotech MicroCap Rip on Licensing Talks - The Globe and Mail - June 15th, 2024
- Syntekabio to Showcase Advanced AI Drug Discovery Technologies at BIO International Convention 2024 - May 23rd, 2024
- Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 23rd, 2024
- Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist... - May 23rd, 2024
- Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first potential drug intervention for Epstein-Barr Virus... - May 23rd, 2024
- Oxurion Announces Results on the Annual Shareholders’ Meeting of 16 May 2024 - May 23rd, 2024
- New York Blood Center Enterprises Celebrates the Expansion of Cell & Gene Therapy GMP Manufacturing Capabilities at the Grand Opening of... - May 23rd, 2024
- Syneos Health Leaders Recognized as PM360 ELITE 100 Award Recipients - May 23rd, 2024
- Kane Biotech Announces First Quarter 2024 Financial Results - May 23rd, 2024
- Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast - May 23rd, 2024
- Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy - May 23rd, 2024
- Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024 - May 23rd, 2024
- 23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results - May 23rd, 2024
- Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting - May 23rd, 2024
- Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting - May 23rd, 2024
- Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head and Neck Squamous Cell Carcinoma at ASCO 2024 - May 23rd, 2024
- Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences - May 23rd, 2024
- NANOBIOTIX to Present at the Jefferies Global Healthcare Conference - May 23rd, 2024
- Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - May 23rd, 2024
- Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual... - May 23rd, 2024
- Biology of stem cells: an overview - PMC - National Center for ... - March 26th, 2024
- Iron Limitation Preserves Youthfulness of Blood Stem Cells - Mirage News - March 13th, 2024
- Mini organs grown from stem cells of unborn babies for the first time in breakthrough - The Mirror - March 9th, 2024
- The Effect of Short-Term NAD3 Supplementation on Circulating Adult Stem Cells in Healthy Individuals Aged 40-70 ... - Cureus - March 7th, 2024
- University of Liverpool Spin-Out Emerges, Pioneering Novel Adult Stem Cell-Based Therapies - India Education Diary - March 7th, 2024
- Scientists have used cells from fluid drawn during pregnancy to grow mini lungs and other organs - Yahoo News Canada - March 6th, 2024
- Japan approves new stem cell-based Alzheimer's therapy By Proactive Investors - Investing.com Australia - January 20th, 2024
- Cyberstalking pits Harvard professor against PubPeer Retraction ... - Retraction Watch - December 5th, 2023
- 10 functional health predictions for 2024, according to a doctor and ... - 1330 WFIN - December 5th, 2023
- See the Brain Like Never Before in This Gorgeous Art - Scientific American - December 5th, 2023
- Geron Announces Publication in The Lancet of Results from the ... - BioSpace - December 5th, 2023
- Stem cell injections could be the key to curing MS - Freethink - December 3rd, 2023
- Jaypirca (pirtobrutinib) Now Approved by U.S. FDA for the ... - Investors | Eli Lilly and Company - December 3rd, 2023
- Comparative Efficacy and Safety of Four JAK Inhibitors for ... - HealthDay - December 3rd, 2023
- City lights up for Francis on Anthony Nolan's birthday - Liverpool Express - December 3rd, 2023
- NOT-AR-23-022: Request for Information on Themes for the NIAMS ... - National Institutes of Health (.gov) - December 3rd, 2023
- December 2023: Intramural Papers of the Month - Environmental Factor Newsletter - December 1st, 2023
- CNA Explains: What is cord blood banking and why do parents do it? - CNA - December 1st, 2023
Recent Comments